Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer

    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    P24 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Mesothelioma Clinical and Trials in Progress

    • Type: Posters
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • Presentations: 8
    • Coordinates: 1/28/2021, 00:00 - 01:00, ePoster Hall
    • +

      P24.03 - A Multicenter Randomized Phase III Trial of Dendritic Cell Maintenance Therapy After Chemotherapy in Mesothelioma; Denim Trial

      00:00 - 00:00  |  Presenter: Robert Anton Belderbos

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA09 - Mesothelioma from Pathogenesis to Therapy

    • Type: Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • Presentations: 8
    • Coordinates: 1/30/2021, 15:30 - 16:30, Scientific Program Auditorium
  • +

    MA11 - Expanding Targetable Genetic Alterations in NSCLC

    • Type: Mini Oral
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 12
    • Coordinates: 1/31/2021, 14:15 - 15:15, Scientific Program Auditorium
    • +

      MA11.04 - Updated Efficacy, Safety and Dosing Management of Poziotinib in Previously Treated EGFR and HER2 Exon 20 NSCLC Patients

      14:20 - 14:25  |  Presenter: Robin Cornelissen

      • Abstract

      Loading...